RecruitingPhase 4ACTRN12607000131459

Oxygen therapy in severe asthma

A randomised controlled trial of the effect of high flow versus titrated oxygen therapy on carbon dioxide (CO2) levels in acute severe asthma


Sponsor

Medical Research Institute of New Zealand

Enrollment

150 participants

Start Date

Mar 1, 2007

Study Type

Interventional

Conditions

Summary

Current standard treatment is to provide high flow oxygen to people with severe asthma. However high flow oxygen may be detrimental and few studies have looked at the use of high flow oxygen in asthma. An alternative treatment is one where the amount of oxygen received is varied depending on the oxygen level in the blood. This study compares these two treatments.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study is for people who come to the emergency department with a severe asthma attack. Standard practice is to give all asthma patients high-flow oxygen, but this study questions whether that is always the right approach. High-flow oxygen may actually be harmful in some cases. This trial compares high-flow oxygen to a 'controlled' approach where oxygen levels in the blood are monitored and the amount of oxygen given is adjusted accordingly — known as titrated oxygen therapy. You may be eligible if: - You are between 18 and 65 years old - You have a history of asthma - You are attending the emergency department with a severe asthma attack - Your lung function (FEV1) is 50% or less of what is expected for you You may NOT be eligible if: - You have been diagnosed with COPD or emphysema - Your asthma is so severe that you need a breathing machine (mechanical ventilation) - You are unconscious, unable to speak, or unable to do a breathing test when you arrive - You have a known chronic breathing condition caused by nerve or muscle disease, chest wall problems, or obesity Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients will be randomly assigned to receive one of 2 oxygen regimes for 1 hour: Continuous high flow oxygen (8L/min via Hudson mask).

Patients will be randomly assigned to receive one of 2 oxygen regimes for 1 hour: Continuous high flow oxygen (8L/min via Hudson mask).


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000131459


Related Trials